Global Intravenous-to-Subcutaneous Drug Sales Market Report 2017

REPORT ID 3602

Global Intravenous-to-Subcutaneous Drug Sales Market Report 2017

Publish Date

14-Dec-17

Pages

107

Format

Electronic (PDF)

Full report description

In this report, the global Intravenous-to-Subcutaneous Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Intravenous-to-Subcutaneous Drug for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Intravenous-to-Subcutaneous Drug market competition by top manufacturers/players, with Intravenous-to-Subcutaneous Drug sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Novartis
    GSK
    Merck
    ...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Prescription
    OCT
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Medical Center

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of contents

Table of Contents

Global Intravenous-to-Subcutaneous Drug Sales Market Report 2017
1 Intravenous-to-Subcutaneous Drug Market Overview
    1.1 Product Overview and Scope of Intravenous-to-Subcutaneous Drug
    1.2 Classification of Intravenous-to-Subcutaneous Drug by Product Category
        1.2.1 Global Intravenous-to-Subcutaneous Drug Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Intravenous-to-Subcutaneous Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Prescription
        1.2.4 OCT
    1.3 Global Intravenous-to-Subcutaneous Drug Market by Application/End Users
        1.3.1 Global Intravenous-to-Subcutaneous Drug Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Medical Center
    1.4 Global Intravenous-to-Subcutaneous Drug Market by Region
        1.4.1 Global Intravenous-to-Subcutaneous Drug Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Intravenous-to-Subcutaneous Drug Status and Prospect (2012-2022)
        1.4.3 China Intravenous-to-Subcutaneous Drug Status and Prospect (2012-2022)
        1.4.4 Europe Intravenous-to-Subcutaneous Drug Status and Prospect (2012-2022)
        1.4.5 Japan Intravenous-to-Subcutaneous Drug Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Intravenous-to-Subcutaneous Drug Status and Prospect (2012-2022)
        1.4.7 India Intravenous-to-Subcutaneous Drug Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Intravenous-to-Subcutaneous Drug (2012-2022)
        1.5.1 Global Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2022)
        1.5.2 Global Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2022)

2 Global Intravenous-to-Subcutaneous Drug Competition by Players/Suppliers, Type and Application
     2.1 Global Intravenous-to-Subcutaneous Drug Market Competition by Players/Suppliers
        2.1.1 Global Intravenous-to-Subcutaneous Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Intravenous-to-Subcutaneous Drug Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Intravenous-to-Subcutaneous Drug (Volume and Value) by Type
        2.2.1 Global Intravenous-to-Subcutaneous Drug Sales and Market Share by Type (2012-2017)
        2.2.2 Global Intravenous-to-Subcutaneous Drug Revenue and Market Share by Type (2012-2017)
    2.3 Global Intravenous-to-Subcutaneous Drug (Volume and Value) by Region
        2.3.1 Global Intravenous-to-Subcutaneous Drug Sales and Market Share by Region (2012-2017)
        2.3.2 Global Intravenous-to-Subcutaneous Drug Revenue and Market Share by Region (2012-2017)
    2.4 Global Intravenous-to-Subcutaneous Drug (Volume) by Application

3 United States Intravenous-to-Subcutaneous Drug (Volume, Value and Sales Price)
    3.1 United States Intravenous-to-Subcutaneous Drug Sales and Value (2012-2017)
        3.1.1 United States Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
        3.1.2 United States Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
        3.1.3 United States Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
    3.2 United States Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Players
    3.3 United States Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Type
    3.4 United States Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Application

4 China Intravenous-to-Subcutaneous Drug (Volume, Value and Sales Price)
    4.1 China Intravenous-to-Subcutaneous Drug Sales and Value (2012-2017)
        4.1.1 China Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
        4.1.2 China Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
        4.1.3 China Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
    4.2 China Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Players
    4.3 China Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Type
    4.4 China Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Application

5 Europe Intravenous-to-Subcutaneous Drug (Volume, Value and Sales Price)
    5.1 Europe Intravenous-to-Subcutaneous Drug Sales and Value (2012-2017)
        5.1.1 Europe Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
        5.1.2 Europe Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
    5.2 Europe Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Players
    5.3 Europe Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Type
    5.4 Europe Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Application

6 Japan Intravenous-to-Subcutaneous Drug (Volume, Value and Sales Price)
    6.1 Japan Intravenous-to-Subcutaneous Drug Sales and Value (2012-2017)
        6.1.1 Japan Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
        6.1.2 Japan Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
    6.2 Japan Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Players
    6.3 Japan Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Type
    6.4 Japan Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Application

7 Southeast Asia Intravenous-to-Subcutaneous Drug (Volume, Value and Sales Price)
    7.1 Southeast Asia Intravenous-to-Subcutaneous Drug Sales and Value (2012-2017)
        7.1.1 Southeast Asia Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
    7.2 Southeast Asia Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Players
    7.3 Southeast Asia Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Type
    7.4 Southeast Asia Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Application

8 India Intravenous-to-Subcutaneous Drug (Volume, Value and Sales Price)
    8.1 India Intravenous-to-Subcutaneous Drug Sales and Value (2012-2017)
        8.1.1 India Intravenous-to-Subcutaneous Drug Sales and Growth Rate (2012-2017)
        8.1.2 India Intravenous-to-Subcutaneous Drug Revenue and Growth Rate (2012-2017)
        8.1.3 India Intravenous-to-Subcutaneous Drug Sales Price Trend (2012-2017)
    8.2 India Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Players
    8.3 India Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Type
    8.4 India Intravenous-to-Subcutaneous Drug Sales Volume and Market Share by Application

9 Global Intravenous-to-Subcutaneous Drug Players/Suppliers Profiles and Sales Data
    9.1 Novartis
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Intravenous-to-Subcutaneous Drug Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Novartis Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 GSK
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Intravenous-to-Subcutaneous Drug Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 GSK Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Merck
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Intravenous-to-Subcutaneous Drug Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Merck Intravenous-to-Subcutaneous Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    ...

10 Intravenous-to-Subcutaneous Drug Maufacturing Cost Analysis
    10.1 Intravenous-to-Subcutaneous Drug Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Intravenous-to-Subcutaneous Drug
    10.3 Manufacturing Process Analysis of Intravenous-to-Subcutaneous Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Intravenous-to-Subcutaneous Drug Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Intravenous-to-Subcutaneous Drug Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Intravenous-to-Subcutaneous Drug Market Forecast (2017-2022)
    14.1 Global Intravenous-to-Subcutaneous Drug Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Intravenous-to-Subcutaneous Drug Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Intravenous-to-Subcutaneous Drug Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Intravenous-to-Subcutaneous Drug Price and Trend Forecast (2017-2022)
    14.2 Global Intravenous-to-Subcutaneous Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Intravenous-to-Subcutaneous Drug Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Intravenous-to-Subcutaneous Drug Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Intravenous-to-Subcutaneous Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Intravenous-to-Subcutaneous Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Intravenous-to-Subcutaneous Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Intravenous-to-Subcutaneous Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Intravenous-to-Subcutaneous Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Intravenous-to-Subcutaneous Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Intravenous-to-Subcutaneous Drug Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global Intravenous-to-Subcutaneous Drug Sales Forecast by Type (2017-2022)
       14.3.2 Global Intravenous-to-Subcutaneous Drug Revenue Forecast by Type (2017-2022)
       14.3.3 Global Intravenous-to-Subcutaneous Drug Price Forecast by Type (2017-2022)
    14.4 Global Intravenous-to-Subcutaneous Drug Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer